1001-5256
2015 Issue 6
..............page:810
Current challenges to primary liver cancer research
YE Shenglong;Liver Cancer Institute;Zhongshan Hospital;Fudan University;
YE Shenglong;Liver Cancer Institute;Zhongshan Hospital;Fudan University;
..............page:819-823
..............page:824-828
he bing men jing mai xue shuan de yi xing gan yan gan ying hua huan zhe , shi yong bu tong ji liang yi nuo gan su kang ning zhi liao de an quan xing he you xiao xing
wang zhong feng ;cui sb;
wang zhong feng ;cui sb;
..............page:828
Explanation of the “Guidelines for the prevention,care and treatment of persons with chronic hepatitis B infection 2015”: non-invasive assessment of liver fibrosis,treatment strategy and implementation of national programs
HU Xiaoyun;LIU Zhihong;SUN Jian;Department of Infectious Disease and Hepatology Unit;Nanfang Hospital;Southern Medical University;
HU Xiaoyun;LIU Zhihong;SUN Jian;Department of Infectious Disease and Hepatology Unit;Nanfang Hospital;Southern Medical University;
..............page:829-832
Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China( 2015 update)
Chinese Society of Liver Cancer;Chinese Anti - Cancer Association;Liver Cancer Study Group;Chinese Society of Hepatology;Chinese Medical Association;Chinese Society of Pathology;Chinese Anti - Cancer Association;Digestive Disease Group;Chinese Society of Pathology;Chinese Medical Association;Hepatic Surgery Group;Chinese Society of Surgery;Chinese Medical Association;Chinese Society of Clinical Oncology;Chinese Anti - Cancer Association;Chinese Pathological Group of Hepatobiliary Tumor and Liver Transplantation;
Chinese Society of Liver Cancer;Chinese Anti - Cancer Association;Liver Cancer Study Group;Chinese Society of Hepatology;Chinese Medical Association;Chinese Society of Pathology;Chinese Anti - Cancer Association;Digestive Disease Group;Chinese Society of Pathology;Chinese Medical Association;Hepatic Surgery Group;Chinese Society of Surgery;Chinese Medical Association;Chinese Society of Clinical Oncology;Chinese Anti - Cancer Association;Chinese Pathological Group of Hepatobiliary Tumor and Liver Transplantation;
..............page:833-839
Updated key points and clinical pathway for NCCN Clinical Practice Guidelines in Oncology: hepatobiliary cancers( Version 2. 2015)
ZHU Peng;XU Zong;WANG Yuming;Department of Internal Medicine;Hospital of 75211;
ZHU Peng;XU Zong;WANG Yuming;Department of Internal Medicine;Hospital of 75211;
..............page:840-849
Interpretation of key points in Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update( 3rd JSH-HCC Guidelines)
WU Yinlian;LIN Su;DONG Jing;Liver Diseases Research Center;The First Affiliated Hospital of Fujian Medical University;
WU Yinlian;LIN Su;DONG Jing;Liver Diseases Research Center;The First Affiliated Hospital of Fujian Medical University;
..............page:850-851
UK guidelines on the management of variceal haemorrhage in cirrhotic patients( 2015) : an excerpt of recommendations
DENG Han;QI Xingshun;GUO Xiaozhong;Department of Gastroenterology;General Hospital of Shenyang Military Area;
DENG Han;QI Xingshun;GUO Xiaozhong;Department of Gastroenterology;General Hospital of Shenyang Military Area;
..............page:852-854
Significance of predictive models / risk calculators for HBV-related hepatocellular carcinoma
DONG Jing;JIANG Jiaji;Center of Liver Disease;The First Affiliated Hospital of Fujian Medical University;
DONG Jing;JIANG Jiaji;Center of Liver Disease;The First Affiliated Hospital of Fujian Medical University;
..............page:855-858
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus
JIA Weidong;LIU Wenbin;Department of Hepatic Surgery & Anhui Key Laboratory of Hepatopancreatobiliary Surgery;Anhui Provincial Hospital;
JIA Weidong;LIU Wenbin;Department of Hepatic Surgery & Anhui Key Laboratory of Hepatopancreatobiliary Surgery;Anhui Provincial Hospital;
..............page:859-862
Comprehensive interventional treatment of hepatocellular carcinoma with portal vein tumor thrombosis
ZHU Xiaoli;Department of Interventional Radiology;The First Affiliated Hospital of Soochow University;
ZHU Xiaoli;Department of Interventional Radiology;The First Affiliated Hospital of Soochow University;
..............page:863-869
A novel approach for treating hepatocellular carcinoma: epigenetic therapy
LI Qiang;CHEN Liang;HUANG Yuxian;First Department of Hepatitis;Shanghai Public Health Clinical Center;
LI Qiang;CHEN Liang;HUANG Yuxian;First Department of Hepatitis;Shanghai Public Health Clinical Center;
..............page:870-875
hcv gan ran hou gan xian wei hua jin zhan
wang zhong feng ;butt aa;
wang zhong feng ;butt aa;
..............page:875
Hepatic stellate cells,Toll-like receptor 4 signaling pathway,and inflammatory fibrotic microenvironment in the development of hepatocellular carcinoma
WU Yujing;GUO Jinsheng;Department of Gastroenterology;Zhongshan Hospital;Fudan University;
WU Yujing;GUO Jinsheng;Department of Gastroenterology;Zhongshan Hospital;Fudan University;
..............page:876-879
Efficacy of transcatheter arterial chemoembolization alone or combined with microwave ablation in treatment of primary large liver cancer: a comparative analysis
CHANG Peng;ZHANG Hongyi;XIAO Mei;Department of Hepatobiliary Surgery;Beijing Air Force General Hospital;
CHANG Peng;ZHANG Hongyi;XIAO Mei;Department of Hepatobiliary Surgery;Beijing Air Force General Hospital;
..............page:880-885
Efficacy and prognostic factors of intensity-modulated radiotherapy for large primary hepatocellular carcinoma
FANG Ziyan;JIN Shuai;LI Gong;Department of Oncology;Tongling People’s Hospital;
FANG Ziyan;JIN Shuai;LI Gong;Department of Oncology;Tongling People’s Hospital;
..............page:886-890
xi bao nei diao wang dan bai zuo kang ji yi zhi hbv de qing chu
gao xiu zhu ; wang chong ;ebert g;
gao xiu zhu ; wang chong ;ebert g;
..............page:890
Therapeutic effect and prognostic analysis of intensity-modulated radiotherapy for primary hepatocellular carcinoma with portal vein and / or inferior vena cava tumor thrombus
HUANG Long;QI Liang;LI Gong;Second Department of Oncology;Clinical College of General Hospital of Armed Police Forces;Anhui Medical University;
HUANG Long;QI Liang;LI Gong;Second Department of Oncology;Clinical College of General Hospital of Armed Police Forces;Anhui Medical University;
..............page:891-894
Efficacy of sorafenib combined with capecitabine in Hui versus Han residents with advanced hepatocellular carcinoma in Sanya,Hainan,China: a comparative analysis
CHEN Long;LIANG Dong;HOU Benxin;Department of Medical Oncology;Nongken Sanya Hospital;
CHEN Long;LIANG Dong;HOU Benxin;Department of Medical Oncology;Nongken Sanya Hospital;
..............page:895-898
Ultrasound-guided percutaneous cinobufagin injection for treatment of portal vein tumor thrombus in primary liver cancer patients
JI Jianfeng;DENG Xiaoli;XIAO Qiujin;The 94th Hospital of PLA;
JI Jianfeng;DENG Xiaoli;XIAO Qiujin;The 94th Hospital of PLA;
..............page:899-902
chang dao jun qun shi diao xiang guan yan zheng dao zhi ji xing yi xian yan de yan jiu jin zhan
qi li na ; wang chong ;tan c;
qi li na ; wang chong ;tan c;
..............page:902
Relationship between tumor location and pain level in CT-guided percutaneous microwave ablation of hepatocellular carcinoma
LI Jinghua;CUI Shichang;SUN Jian;Interventional Centre of Liver Diseases and cancer;Beijing You An Hospital;Capital Medical University;
LI Jinghua;CUI Shichang;SUN Jian;Interventional Centre of Liver Diseases and cancer;Beijing You An Hospital;Capital Medical University;
..............page:903-906
Clinical characteristics of patients with HBs Ag( + ) versus HBs Ag(-) / HBc Ab( + ) primary hepatic carcinoma treated by hepatectomy: a comparative analysis
YANG Keli;YANG Zhan;GUAN Yujuan;Guangzhou 8th People’s Hospital;
YANG Keli;YANG Zhan;GUAN Yujuan;Guangzhou 8th People’s Hospital;
..............page:907-909
Usage analysis of human serum albumin in patients with liver cancer and liver cirrhosis after hepatectomy
HUANG Donghai;SHI Jianshe;ZHANG Chenghua;Department of General Surgery;180 Hospital of PLA;
HUANG Donghai;SHI Jianshe;ZHANG Chenghua;Department of General Surgery;180 Hospital of PLA;
..............page:910-914
man xing yi xing gan yan huan zhe hbsag xue qing qing chu hou gan xi bao ai de fa sheng lv : xu yao jian ce
wang xiao mei ; wen xiao yu ;kim ga;
wang xiao mei ; wen xiao yu ;kim ga;
..............page:914
Clinical analysis of blood amino acids and trace elements in patients with hepatocellular carcinoma
ZHAO Yuping;HAN Xiuqing;XUE Shubao;Department of Laboratory;Tangshan Maternal and Child Health Hospital;
ZHAO Yuping;HAN Xiuqing;XUE Shubao;Department of Laboratory;Tangshan Maternal and Child Health Hospital;
..............page:915-917
Therapeutic comparison between radiofrequency ablation and percutaneous ethanol injection in treatment of primary liver cancer: a meta-analysis
YIN Yu;NI Caifang;LI Zhi;Department of Interventional Radiology;The First Affiliated Hospital of Soochow University;
YIN Yu;NI Caifang;LI Zhi;Department of Interventional Radiology;The First Affiliated Hospital of Soochow University;
..............page:918-921
Efficacy and safety of octreotide in treatment of hepatocellular carcinoma: a meta-analysis
ZHANG Yuhuai;LUO Changjiang;Department of General Surgery;The Second Hospital of Lanzhou University;
ZHANG Yuhuai;LUO Changjiang;Department of General Surgery;The Second Hospital of Lanzhou University;
..............page:922-926
Preoperative neutrophil-lymphocyte ratio is an independent prognostic factor for hepatocellular carcinoma after radical resection
ZHANG Tingting;ZHAO Xiangqian;LIU Zhe;Department of Oncology;Chinese PLA General Hospital;
ZHANG Tingting;ZHAO Xiangqian;LIU Zhe;Department of Oncology;Chinese PLA General Hospital;
..............page:927-931
Angiogenesis-related factors in various clinical stages of hepatitis B-related hepatocellular carcinoma
HAN Zhen;SUN Huanqin;JIANG Na;Beijing Youan Hospital;Capital Medical University;
HAN Zhen;SUN Huanqin;JIANG Na;Beijing Youan Hospital;Capital Medical University;
..............page:932-935
da ma su shou ti 1 tong guo duo zhong ji zhi cu jin gan xi bao ai de fa sheng he jin zhan
yang kun ; wang chong ;mukhopadhyay b;
yang kun ; wang chong ;mukhopadhyay b;
..............page:935
Correlation between interleukin-6 and primary hepatocellular carcinoma: a meta-analysis
LI Xia;SHI Yongyu;Department of Internal Medicine;The First People’s Hospital of Ji’nan;
LI Xia;SHI Yongyu;Department of Internal Medicine;The First People’s Hospital of Ji’nan;
..............page:936-942
zu duan xi bao nei diao wang yi zhi ji ke yi qing chu hbv
gao xiu zhu ; wang chong ;ebert g;
gao xiu zhu ; wang chong ;ebert g;
..............page:942
Effects of PARP-1 inhibitors AG-014699 and AZD2281 on proliferation and apoptosis of human hepatoma cell line HepG2
DU Senrong;MAO Xiaorong;XIAO Ping;The First Clinical Medical College;Lanzhou University;
DU Senrong;MAO Xiaorong;XIAO Ping;The First Clinical Medical College;Lanzhou University;
..............page:943-946
Mirabilite umbilical compress in treatment of ascites in liver cirrhosis: a meta-analysis
ZHANG Wenwen;QI Xingshun;GUO Xiaozhong;Department of Gastroenterology;General Hospital of Shenyang Military Area Command;
ZHANG Wenwen;QI Xingshun;GUO Xiaozhong;Department of Gastroenterology;General Hospital of Shenyang Military Area Command;
..............page:947-950
Effects of conventional versus laparoscopic surgery in treatment of congenital bile duct dilatation: a comparative analysis
CHEN Houbin;HUANG Wei;Department of Hepatobiliary Surgery;Gong’an County People’s Hospital;
CHEN Houbin;HUANG Wei;Department of Hepatobiliary Surgery;Gong’an County People’s Hospital;
..............page:951-954
bing du xing he fei bing du xing man xing gan zang ji bing zhong gan rao su rs12979860 ji yin xing yu gan xian wei hua de xiang guan xing yan jiu
wu rui hong ; wen xiao yu ;eslam m;
wu rui hong ; wen xiao yu ;eslam m;
..............page:954
Investigation of impairment of liver function in local residents of Miaofeng Village,Wushan County,China
YANG Zhongxia;MAO Xiaorong;YUAN Hong;The First Hospital of Lanzhou University;
YANG Zhongxia;MAO Xiaorong;YUAN Hong;The First Hospital of Lanzhou University;
..............page:955-957
Diagnosis and treatment of hepatocellular carcinoma after 8-year treatment of decompensated HBV-related liver cirrhosis: a report of one case
HAO Juan;XING Feng;ZHAO Zhimin;Institute of Liver Diseases;Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
HAO Juan;XING Feng;ZHAO Zhimin;Institute of Liver Diseases;Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
..............page:958-960
..............page:960
A case of hepatic epithelioid hemangioendothelioma
WANG Fengjiao;LIU Kaiyan;QI Yue;Department of Hepatology;The First Hospital of Jilin University;
WANG Fengjiao;LIU Kaiyan;QI Yue;Department of Hepatology;The First Hospital of Jilin University;
..............page:961-962
Systemic sclerosis with gallbladder stone disease: a report of one case
DAI Shulong;YANG Shiyong;YANG Kunxing;Department of General Surgery;Nanjing Hospital Affiliated to Nanjing Medical University;
DAI Shulong;YANG Shiyong;YANG Kunxing;Department of General Surgery;Nanjing Hospital Affiliated to Nanjing Medical University;
..............page:963-964
..............page:964
Progress in comprehensive treatment of primary liver cancer
ZHU Puli;YIN Chao;FENG Jianlong;Department of General Surgery;The Fourth People’s Hospital of Shaanxi Province;
ZHU Puli;YIN Chao;FENG Jianlong;Department of General Surgery;The Fourth People’s Hospital of Shaanxi Province;
..............page:965-968
The progress of Fibro Scan technique for diagnosis of hepatocellular carcinoma value
LI Mi;NIE Qinghe;The Center of Infectious Disease Diagnosis and Treatment of PLA;Tangdu Hospital;Forth Military Medical University;
LI Mi;NIE Qinghe;The Center of Infectious Disease Diagnosis and Treatment of PLA;Tangdu Hospital;Forth Military Medical University;
..............page:969-973
lai di pa wei lian he suo fei bu wei zhi liao hcv1 xing bing xing gan yan ji dai chang qi gan ying hua huan zhe : yi xiang zheng ti an quan xing ji you xiao xing fen xi
wang feng zuo ; wen xiao yu ;reddy kr;
wang feng zuo ; wen xiao yu ;reddy kr;
..............page:973
New progress in treatment of hepatocellular carcinoma with portal vein tumor thrombus
CHEN Peng;LI Fei;Department of Chronic Liver Disease;Tianjin Second People’s Hospital;
CHEN Peng;LI Fei;Department of Chronic Liver Disease;Tianjin Second People’s Hospital;
..............page:974-976
Diagnosis and treatment of hepatocellular carcinoma from a new perspective of miRNAs
LI Qiang;ZHUO Qibin;HUANG Yuxian;First Department of Hepatitis;Shanghai Public Health Clinical Center;Fudan University;
LI Qiang;ZHUO Qibin;HUANG Yuxian;First Department of Hepatitis;Shanghai Public Health Clinical Center;Fudan University;
..............page:977-981
Research progress in c-Met and hepatocellular carcinoma
WANG Changqing;GUO Weiwei;LIU Zheng;Medical Center for Digestive Diseases;The Second Clinical Medical School & The Second Affiliated Hospital;Nanjing Medical University;
WANG Changqing;GUO Weiwei;LIU Zheng;Medical Center for Digestive Diseases;The Second Clinical Medical School & The Second Affiliated Hospital;Nanjing Medical University;
..............page:982-984
Clinical research progress in Erlotinib treatment for hepatocellular carcinoma
GAO Fan;QI Xingshun;Medical Department;202 Hospital of PLA;
GAO Fan;QI Xingshun;Medical Department;202 Hospital of PLA;
..............page:985-988
..............page:988
PI3K / Akt / mTOR signaling pathway and malignant hepatobiliary tumors
CHEN Xuxiao;CHEN Yongjun;Department of General surgery;Ruijin Hospital;Shanghai Jiao Tong University School of Medicine;
CHEN Xuxiao;CHEN Yongjun;Department of General surgery;Ruijin Hospital;Shanghai Jiao Tong University School of Medicine;
..............page:989-991
Prevention and treatment of liver fibrosis by regulating liver regeneration
LI Hanmin;Institute of Liver Diseases of The Affiliated Hospital of Hubei University of Chinese Medicine;The Cellular and Molecular Biology Laboratory of State Administration of Traditional Chinese Medicine;
LI Hanmin;Institute of Liver Diseases of The Affiliated Hospital of Hubei University of Chinese Medicine;The Cellular and Molecular Biology Laboratory of State Administration of Traditional Chinese Medicine;
..............page:992-995
..............page:995
Application of hepatobiliary-specific MRI contrast agent Gd-EOB-DTPA in preoperative evaluation of hepatobiliary patients
JIANG Jiayun;LI Xuesong;MA Kuansheng;Institute of Hepatobiliary Surgery;Southwest Hospital;Third Military Medical University;
JIANG Jiayun;LI Xuesong;MA Kuansheng;Institute of Hepatobiliary Surgery;Southwest Hospital;Third Military Medical University;
..............page:996-999